Siteman Cancer Center earns highest NCI rating

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis received an “exceptional” rating from NCI during its site visit for 2020.

The evaluation resulted in a nearly perfect score from NCI.

Siteman earned its latest exceptional rating based on a January site visit by 22 researchers and administrators from academic cancer centers across the U.S. During the visit, Washington University researchers and physicians presented research programs that included:

  • Siteman’s portfolio of more than 600 clinical studies and the cancer center’s enrollment of more than 12,000 patients in clinical studies per year.

  • Genomic research to identify personalized targets and create personalized vaccines.

  • The use of ultrasound and photoacoustic imaging, which relies on light and sound rather than tissue samples, to diagnose ovarian cancer.

  • Community-based research to understand and reduce cancer disparities and lessen the burden of cancer in our entire region.

  • Improvements in colorectal cancer screening in urban and rural areas.

  • The use of cellular therapies and CAR-T cell therapy to treat blood and bone marrow cancers.

  • The development of novel immunotherapies for the prevention and treatment of cancer.

  • Community outreach and education, and enhanced access to cancer care.

  • The range of educational opportunities available at Siteman, from mentorships for high school and college students to advanced training for medical students and junior faculty.

Siteman was named Missouri’s only NCI-designated Cancer Center in 2001 and the state’s only Comprehensive Cancer Center in 2005. Today, Siteman treats more than 75,000 unique patients, including 12,000 newly diagnosed patients, every year.

Table of Contents

YOU MAY BE INTERESTED IN

Two years ago, Dan Theodorescu made a discovery that could alter biology textbooks: The Y chromosome, widely considered to be a “functional wasteland,” has functions beyond sex determination—and in fact plays a role in cancer biology. 
Silverstein during his surgical oncology fellowship, c. 1972This month on the Cancer History Project Podcast, Melvin J. Silverstein, Medical Director of Hoag Breast Center and the Gross Family Foundation Endowed Chair in Oncoplastic Breast Surgery at USC, sat down with Stacy Wentworth, radiation oncologist and medical historian, to reflect on his career—and founding the first free-standing breast center.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login